Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with Developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545 C>A mutation in DNM1 gene.-SomaxBio

Phone

Phone：+86-400-8228-027

WeChat

Generation of an induced pluripotent stem cell line (FDCHI007-A) derived from a patient with Developmental and epileptic encephalopathy Type 31 carrying heterozygous c.545 C>A mutation in DNM1 gene.

Service

iPSC Line Generation and Characterization iPSC Gene Editing iPSC Cell Differentiation iPSC Organoid Differentiation

Questions

When thawing and seeding iPSC cells, most of them are found to be in a single-cell morphology and hardly attach after 24 hours. What is the cause, and how should it be handled? Precautions for iPSC cell passaging Cells exhibit vacuolization. The significance of establishing iPSC lines from the blood of patients with rare diseases

We are committed to providing research institutions, pharmaceutical companies, and clinical translation research with one-stop iPSC-related technologies, products, and solutions.

iPSC Product

iPSC Cell Products

iPSC-derived Cells

iPSC Culture Reagents

iPSC Cell Differentiation Kits

iPSC Organoid Differentiation Kits

iPSC Service

iPSC Line Generation and Characterization

iPSC Gene Editing

iPSC Cell Differentiation

iPSC Organoid Differentiation

Quick Links

Information Lookup

Contact Us

Building 28, No. 18, Lane 99, Chun Guang Road, Minhang District, Shanghai, China

+86-400-8228-027

soma@somaxbio.com

© 2026 Soma Biotechnology (Shanghai) Co., Ltd. All rights reserved.沪ICP备2026003108号

沪公网安备31011202022106号